1st Quarter - Report

PARATEK PHARMACEUTICALS for PARATEK PHARMACEUTICALS

Firm
Client
Income
—
Expenses
$20,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY 27 DOD Appropriations FY 27 HHS Appropriations Biodefense Funding

Foreign entity interest: Foreign private equity firm investment in company.

LobbyistCovered position, as disclosed
BENJAMIN NOVAK —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Office of Management & Budget (OMB); Defense, Dept of (DOD)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.